Skip to content

Author

A. Amin

We have 3 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Comparative in silico evaluation of steroidal and non-steroidal sulfamates as potential human steroid sulfatase inhibitors.

Steroid sulfatase (STS) is a membrane-bound enzyme and a key therapeutic target for hormone-dependent disorders. This study evaluates four sulfamate-based STS inhibitors Coumate, Irosustat (STX64), STX213, and STX1938 across both the catalytic core (Site 1) and the secondary membrane-gate vestibule (Site 2) of human ST...

Bahez Ahmed Abdalla, A. Amin, A. K. Ali et al. · 0 citations
Aug 2026

Halogenated Phenylsulfamates as hCA IX Inhibitors: In Silico Evaluation of Dynamic Stability and Pharmacokinetic Safety

Therapeutic targeting of human Carbonic Anhydrase IX (hCA IX) is critical for cancer treatment, as the enzyme regulates pH homeostasis and facilitates the survival of hypoxic tumor cells. This in silico study presents a multi‐layered computational investigation of a series of 4‐halogenated phenylsulfamates (4: Cl, 5:...

A. Amin, Omed Qadir Ibrahim, A. K. Ali et al. · 1 citation
Aug 2026

In silico evaluation of novel metabolites from Tricholoma pardinum: Insights into drug-likeness, toxicity and target interactions via molecular docking and dynamics.

Six previously uncharacterized metabolites isolated from the poisonous mushroom Tricholoma pardinum are investigated using an integrated in silico approach to evaluate their therapeutic potential, highlighting the potential of metabolites from T. pardinum as novel scaffolds for developing anticancer agents targeting PA...

A. Amin, H. M. Amin, A. R. Hamad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.